Son güncelleme :
19/11/2024
Beta-blokör   Sotalol hydrochloride  
Oral solüsyon / oral çözelti
Farmasötik preparatlar Kararlılığı Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Kaynaklar pdf
   Kimyasal yapı   

Oral solüsyon / oral çözelti
Kaynaklar   Oral solüsyon / oral çözelti   Kaynaklar : Sotalol hydrochloride  
tip yayın
2548 Dergi Nahata MC, Morosco RS.
Stability of Sotalol in Two Liquid Formulations at Two Temperatures
Ann Pharmacotherapy 2003 ;37:506-509.
2591 Dergi Dupuis LL, James G, Bacola G.
Stability of a sotalol hydrochloride oral liquid formulation.
Can J Hosp Pharm 1988 ; 41: 121-123.
3682 Dergi Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P.
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
EJHP 2016 ;23:33-37
4177 Dergi Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526

  Mentions Légales